COMPANY DESCRIPTIONAbiologics Inc. is a privately held early-stage biotechnology company on a mission to make biology better through an innovative therapeutic modality. We are pioneering the development of Synteins a transformational class of macromolecular medicines unlocked by novel
COMPANY DESCRIPTIONAbiologics Inc. is a privately held early-stage biotechnology company on a mission to make biology better through an innovative therapeutic modality. We are pioneering the development of Synteins a transformational class of macromolecular medicines unlocked by novel
Abiologics
COMPANY DESCRIPTIONAbiologics Inc. is a privately held early-stage biotechnology company on a mission to make biology better through an innovative therapeutic modality. We are pioneering the development of Synteins a transformational class of macromolecular medicines unlocked by novel
COMPANY DESCRIPTIONAbiologics Inc. is a privately held early-stage biotechnology company on a mission to make biology better through an innovative therapeutic modality. We are pioneering the development of Synteins a transformational class of macromolecular medicines unlocked by novel
AboutAbiologicsAbiologicsis a Flagship Pioneering company developingSynteins a transformative class of fully synthetic proteins composed entirely of artificial building blocks such as D-amino acids and TMare designed to transcend the limitations of traditional biologics with improved
AboutAbiologicsAbiologicsis a Flagship Pioneering company developingSynteins a transformative class of fully synthetic proteins composed entirely of artificial building blocks such as D-amino acids and TMare designed to transcend the limitations of traditional biologics with improved